BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24429578)

  • 1. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes.
    Butcher MJ; Hallinger D; Garcia E; Machida Y; Chakrabarti S; Nadler J; Galkina EV; Imai Y
    Diabetologia; 2014 Mar; 57(3):491-501. PubMed ID: 24429578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?
    Westwell-Roper C; Ehses JA
    Diabetologia; 2014 Mar; 57(3):447-50. PubMed ID: 24362729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.
    Igoillo-Esteve M; Marselli L; Cunha DA; Ladrière L; Ortis F; Grieco FA; Dotta F; Weir GC; Marchetti P; Eizirik DL; Cnop M
    Diabetologia; 2010 Jul; 53(7):1395-405. PubMed ID: 20369226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients.
    Reddy S; Zeng N; Al-Diery H; Jung D; Yeu C; Joret MO; Merrilees MJ; Wu F
    Diabetologia; 2015 May; 58(5):1024-35. PubMed ID: 25687234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulitis in human diabetes: a histological evaluation of donor pancreases.
    Lundberg M; Seiron P; Ingvast S; Korsgren O; Skog O
    Diabetologia; 2017 Feb; 60(2):346-353. PubMed ID: 27796420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
    Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
    Scholz H; Lund T; Dahle MK; Collins JL; Korsgren O; Wang JE; Foss A
    Diabetologia; 2009 Jul; 52(7):1352-62. PubMed ID: 19415233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.
    Quesada-Masachs E; Zilberman S; Rajendran S; Chu T; McArdle S; Kiosses WB; Lee JM; Yesildag B; Benkahla MA; Pawlowska A; Graef M; Pfeiffer S; Mikulski Z; von Herrath M
    Diabetologia; 2022 Feb; 65(2):387-401. PubMed ID: 34932134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
    Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
    J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STEAP4 expression in human islets is associated with differences in body mass index, sex, HbA1c, and inflammation.
    Gordon HM; Majithia N; MacDonald PE; Fox JEM; Sharma PR; Byrne FL; Hoehn KL; Evans-Molina C; Langman L; Brayman KL; Nunemaker CS
    Endocrine; 2017 Jun; 56(3):528-537. PubMed ID: 28405880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Wreven E; Ruiz de Adana MS; Hardivillé S; Gmyr V; Kerr-Conte J; Chetboun M; Pasquetti G; Delalleau N; Thévenet J; Coddeville A; Vallejo Herrera MJ; Hinden L; Benavides Espínola IC; Gómez Duro M; Sanchez Salido L; Linares F; Bermúdez-Silva FJ; Tam J; Bonner C; Egan JM; Olveira G; Colomo N; Pattou F; González-Mariscal I
    Diabetologia; 2024 Jun; ():. PubMed ID: 38864887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.
    Yeung TY; Seeberger KL; Kin T; Adesida A; Jomha N; Shapiro AM; Korbutt GS
    PLoS One; 2012; 7(5):e38189. PubMed ID: 22666480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets.
    Grieco FA; Moore F; Vigneron F; Santin I; Villate O; Marselli L; Rondas D; Korf H; Overbergh L; Dotta F; Marchetti P; Mathieu C; Eizirik DL
    Diabetologia; 2014 Mar; 57(3):502-11. PubMed ID: 24352375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
    Ling C; Del Guerra S; Lupi R; Rönn T; Granhall C; Luthman H; Masiello P; Marchetti P; Groop L; Del Prato S
    Diabetologia; 2008 Apr; 51(4):615-22. PubMed ID: 18270681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped.
    Tariq M; de Souza AH; Bensellam M; Chae H; Jaffredo M; Close AF; Deglasse JP; Santos LRB; Buemi A; Mourad NI; Wojtusciszyn A; Raoux M; Gilon P; Broca C; Jonas JC
    Diabetologia; 2023 Apr; 66(4):709-723. PubMed ID: 36459178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the prostaglandin D
    Abadpour S; Tyrberg B; Schive SW; Huldt CW; Gennemark P; Ryberg E; Rydén-Bergsten T; Smith DM; Korsgren O; Skrtic S; Scholz H; Winzell MS
    Diabetologia; 2020 Jul; 63(7):1355-1367. PubMed ID: 32350565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
    Bennet H; Balhuizen A; Medina A; Dekker Nitert M; Ottosson Laakso E; Essén S; Spégel P; Storm P; Krus U; Wierup N; Fex M
    Peptides; 2015 Sep; 71():113-20. PubMed ID: 26206285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function.
    Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
    Diabetologia; 2011 Dec; 54(12):3083-92. PubMed ID: 21901281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.